Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 160

1.

Methadone serum concentrations and influencing factors: A naturalistic observational study.

Chalabianloo F, Westin AA, Skogvoll E, Bramness JG, Spigset O.

Psychopharmacology (Berl). 2019 May 28. doi: 10.1007/s00213-019-05277-1. [Epub ahead of print]

PMID:
31139877
2.

No easy access to health data.

Bramness JG.

Tidsskr Nor Laegeforen. 2019 Apr 24;139(8). doi: 10.4045/tidsskr.19.0234. Print 2019 May 7. Norwegian. No abstract available.

3.

Mortality, cause of death and risk factors in patients with alcohol use disorder alone or poly-substance use disorders: a 19-year prospective cohort study.

Hjemsæter AJ, Bramness JG, Drake R, Skeie I, Monsbakken B, Benth JŠ, Landheim AS.

BMC Psychiatry. 2019 Mar 28;19(1):101. doi: 10.1186/s12888-019-2077-8.

4.

Characterization of gut microbiota composition and functions in patients with chronic alcohol overconsumption.

Bjørkhaug ST, Aanes H, Neupane SP, Bramness JG, Malvik S, Henriksen C, Skar V, Medhus AW, Valeur J.

Gut Microbes. 2019 Mar 20:1-13. doi: 10.1080/19490976.2019.1580097. [Epub ahead of print]

PMID:
30894059
5.

Undiagnosed cardiovascular disease prior to cardiovascular death in individuals with severe mental illness.

Heiberg IH, Jacobsen BK, Balteskard L, Bramness JG, Naess Ø, Ystrom E, Reichborn-Kjennerud T, Hultman CM, Nesvåg R, Høye A.

Acta Psychiatr Scand. 2019 Jun;139(6):558-571. doi: 10.1111/acps.13017. Epub 2019 Mar 29.

6.

Explaining the association between anxiety disorders and alcohol use disorder: A twin study.

Torvik FA, Rosenström TH, Gustavson K, Ystrom E, Kendler KS, Bramness JG, Czajkowski N, Reichborn-Kjennerud T.

Depress Anxiety. 2019 Jun;36(6):522-532. doi: 10.1002/da.22886. Epub 2019 Mar 5.

PMID:
30838764
7.

A longitudinal study of cannabis use increasing the use of asthma medication in young Norwegian adults.

Bramness JG, von Soest T.

BMC Pulm Med. 2019 Feb 26;19(1):52. doi: 10.1186/s12890-019-0814-x.

8.

Antipsychotic drugs for more than two years?

Bramness JG, Røssberg JI.

Tidsskr Nor Laegeforen. 2018 Nov 26;138(19). doi: 10.4045/tidsskr.18.0844. Print 2018 Nov 27. Norwegian. No abstract available.

9.

Use of drugs for alcohol use disorder in Norway 2004–16.

Heldal AT, Skurtveit S, Lobmaier PPK, Vederhus JK, Bramness JG.

Tidsskr Nor Laegeforen. 2018 Nov 8;138(18). doi: 10.4045/tidsskr.18.0383. Print 2018 Nov 13. Norwegian.

10.

PTSD patients show increasing cytokine levels during treatment despite reduced psychological distress.

Toft H, Bramness JG, Lien L, Abebe DS, Wampold BE, Tilden T, Hestad K, Neupane SP.

Neuropsychiatr Dis Treat. 2018 Sep 17;14:2367-2378. doi: 10.2147/NDT.S173659. eCollection 2018.

11.

Kvetiapin brukes for mye.

Gjerden P, Bramness JG, Slørdal L.

Tidsskr Nor Laegeforen. 2018 Sep 3;138(13). doi: 10.4045/tidsskr.18.0535. Print 2018 Sep 4. Norwegian. No abstract available.

12.

Total and cause-specific standardized mortality ratios in patients with schizophrenia and/or substance use disorder.

Heiberg IH, Jacobsen BK, Nesvåg R, Bramness JG, Reichborn-Kjennerud T, Næss Ø, Ystrom E, Hultman CM, Høye A.

PLoS One. 2018 Aug 23;13(8):e0202028. doi: 10.1371/journal.pone.0202028. eCollection 2018.

13.

A Survey on the Medical Use of Cannabis in Europe: A Position Paper.

Bramness JG, Dom G, Gual A, Mann K, Wurst FM.

Eur Addict Res. 2018;24(4):201-205. doi: 10.1159/000492757. Epub 2018 Aug 22.

PMID:
30134238
14.

The effect of trauma and alcohol on the relationship between level of cytokines and depression among patients entering psychiatric treatment.

Toft H, Neupane SP, Bramness JG, Tilden T, Wampold BE, Lien L.

BMC Psychiatry. 2018 Apr 10;18(1):95. doi: 10.1186/s12888-018-1677-z.

15.

Increase in diagnosis of depressive disorders contributes to the increase in antidepressant use in adolescents.

Skurtveit S, Bramness JG, Hjellvik V, Hartz I, Nesvåg R, Hauge LJ, Handal M.

Acta Psychiatr Scand. 2018 May;137(5):413-421. doi: 10.1111/acps.12877. Epub 2018 Apr 5.

PMID:
29623693
16.

Circulating cytokine levels are associated with symptoms of depression and anxiety among people with alcohol and drug use disorders.

Martinez P, Lien L, Zemore S, Bramness JG, Neupane SP.

J Neuroimmunol. 2018 May 15;318:80-86. doi: 10.1016/j.jneuroim.2018.02.011. Epub 2018 Feb 22.

17.

The incidence, psychiatric co-morbidity and pharmacological treatment of severe mental disorders in children and adolescents.

Nesvåg R, Bramness JG, Handal M, Hartz I, Hjellvik V, Skurtveit S.

Eur Psychiatry. 2018 Mar;49:16-22. doi: 10.1016/j.eurpsy.2017.12.009. Epub 2018 Feb 3.

PMID:
29366845
18.

[About LSD in the reading room, farmers and proportions].

Bramness JG.

Tidsskr Nor Laegeforen. 2018 Jan 22;138(2). doi: 10.4045/tidsskr.17.1020. Print 2018 Jan 23. Norwegian. No abstract available.

19.

[No title available]

Mørland J, Bramness JG.

Tidsskr Nor Laegeforen. 2018 Jan 22;138(2). doi: 10.4045/tidsskr.18.0014. Print 2018 Jan 23. Norwegian. No abstract available.

PMID:
29357622
Free Article
20.

Dual Diagnoses – Severe Mental Illness and Substance Use Disorder. Part 2 – Effect of Psychosocial Interventions [Internet].

Kirk I, Leiknes KA, Laru L, Hammerstrøm KT, Bramness JG, Gråwe RW, Haugerud H, Helseth V, Landheim A, Lossius K, Waal H.

Oslo, Norway: Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH); 2008 Oct.

21.

Dual Diagnoses – Substance Use Disorder and Severe Mental Illness: Part 1 – Accuracy of Screening and Diagnostic Instruments [Internet].

Larun L, Helseth V, Bramness JG, Haugerud H, Høie B, Gråwe RW, Kornør H, Landhein A, Lossius K, Hammerstrøm KT, Waal H.

Oslo, Norway: Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH); 2007 Dec.

22.

Attention Deficit Hyperactivity Disorder Symptoms are Common in Patients in Opioid Maintenance Treatment.

Fiksdal Abel K, Ravndal E, Clausen T, Bramness JG.

Eur Addict Res. 2017;23(6):298-305. doi: 10.1159/000484240. Epub 2018 Jan 10.

PMID:
29320768
23.

Perceived Self-Control is Related to Mental Distress in Patients Entering Substance Use Disorder Treatment.

Abel KF, Skjærvø I, Ravndal E, Clausen T, Bramness JG.

Subst Use Misuse. 2018 Jul 29;53(9):1454-1462. doi: 10.1080/10826084.2017.1413114. Epub 2018 Jan 5.

PMID:
29303399
24.

[Effects of cannabis last longer than expected].

Mørland J, Bramness JG.

Tidsskr Nor Laegeforen. 2017 Oct 30;137(20). doi: 10.4045/tidsskr.17.0429. Print 2017 Oct 31. Norwegian. No abstract available.

25.

Diagnostic and genetic overlap of three common mental disorders in structured interviews and health registries.

Torvik FA, Ystrom E, Gustavson K, Rosenström TH, Bramness JG, Gillespie N, Aggen SH, Kendler KS, Reichborn-Kjennerud T.

Acta Psychiatr Scand. 2018 Jan;137(1):54-64. doi: 10.1111/acps.12829. Epub 2017 Oct 26.

26.

Hypnotics use in children 0-18 months: moderate agreement between mother-reported survey data and prescription registry data.

Holdø I, Bramness JG, Handal M, Torgersen L, Reichborn-Kjennerud T, Ystrøm E, Nordeng H, Skurtveit S.

J Pharm Policy Pract. 2017 Sep 8;10:28. doi: 10.1186/s40545-017-0117-7. eCollection 2017.

27.

Comorbid post-traumatic stress disorder in alcohol use disorder: relationships to demography, drinking and neuroimmune profile.

Neupane SP, Bramness JG, Lien L.

BMC Psychiatry. 2017 Aug 29;17(1):312. doi: 10.1186/s12888-017-1479-8.

28.

Combined Effect of CYP2B6 Genotype and Other Candidate Genes on a Steady-State Serum Concentration of Methadone in Opioid Maintenance Treatment.

Kringen MK, Chalabianloo F, Bernard JP, Bramness JG, Molden E, Høiseth G.

Ther Drug Monit. 2017 Oct;39(5):550-555. doi: 10.1097/FTD.0000000000000437.

PMID:
28723731
29.

Psychosis relapse, medication non-adherence, and cannabis.

Engh JA, Bramness JG.

Lancet Psychiatry. 2017 Aug;4(8):578-579. doi: 10.1016/S2215-0366(17)30254-7. Epub 2017 Jul 10. No abstract available.

30.

The antipsychotic agent quetiapine is increasingly not used as such: dispensed prescriptions in Norway 2004-2015.

Gjerden P, Bramness JG, Tvete IF, Slørdal L.

Eur J Clin Pharmacol. 2017 Sep;73(9):1173-1179. doi: 10.1007/s00228-017-2281-8. Epub 2017 Jun 16.

PMID:
28623386
31.

Chronic alcohol overconsumption may alter gut microbial metabolism: a retrospective study of 719 13C-D-xylose breath test results.

Bjørkhaug ST, Skar V, Medhus AW, Tollisen A, Bramness JG, Valeur J.

Microb Ecol Health Dis. 2017 Mar 17;28(1):1301725. doi: 10.1080/16512235.2017.1301725. eCollection 2017.

32.

Erratum to: Exploring functional data analysis and wavelet principal component analysis on ecstasy (MDMA) wastewater data.

Salvatore S, Bramness JG, Røislien J.

BMC Med Res Methodol. 2017 Feb 23;17(1):34. doi: 10.1186/s12874-017-0311-y. No abstract available.

33.

Substance use and sociodemographic background as risk factors for lifetime psychotic experiences in a non-clinical sample.

Rognli EB, Bramness JG, Skurtveit S, Bukten A.

J Subst Abuse Treat. 2017 Mar;74:42-47. doi: 10.1016/j.jsat.2016.12.007. Epub 2016 Dec 29.

PMID:
28132699
34.

Cytokine Changes following Acute Ethanol Intoxication in Healthy Men: A Crossover Study.

Neupane SP, Skulberg A, Skulberg KR, Aass HC, Bramness JG.

Mediators Inflamm. 2016;2016:3758590. doi: 10.1155/2016/3758590. Epub 2016 Dec 20.

35.

Increased levels of the oxidative stress biomarker 8-iso-prostaglandin F in wastewater associated with tobacco use.

Ryu Y, Gracia-Lor E, Bade R, Baz-Lomba JA, Bramness JG, Castiglioni S, Castrignanò E, Causanilles A, Covaci A, de Voogt P, Hernandez F, Kasprzyk-Hordern B, Kinyua J, McCall AK, Ort C, Plósz BG, Ramin P, Rousis NI, Reid MJ, Thomas KV.

Sci Rep. 2016 Dec 15;6:39055. doi: 10.1038/srep39055.

36.

Assessing prescription drug abuse using functional principal component analysis (FPCA) of wastewater data.

Salvatore S, Røislien J, Baz-Lomba JA, Bramness JG.

Pharmacoepidemiol Drug Saf. 2017 Mar;26(3):320-326. doi: 10.1002/pds.4127. Epub 2016 Nov 11.

PMID:
27862608
37.

Hepatitis C Treatment Uptake among Patients Who Have Received Opioid Substitution Treatment: A Population-Based Study.

Midgard H, Bramness JG, Skurtveit S, Haukeland JW, Dalgard O.

PLoS One. 2016 Nov 15;11(11):e0166451. doi: 10.1371/journal.pone.0166451. eCollection 2016.

38.

[Does stronger cannabis cause more health problems?].

Vindenes V, Bramness JG, Bretteville-Jensen AL, Mørland J, Bachs L.

Tidsskr Nor Laegeforen. 2016 Nov 8;136(20):1736-1738. eCollection 2016 Nov. Norwegian. No abstract available.

39.

Mental disorder diagnoses among children and adolescents who use antipsychotic drugs.

Nesvåg R, Hartz I, Bramness JG, Hjellvik V, Handal M, Skurtveit S.

Eur Neuropsychopharmacol. 2016 Sep;26(9):1412-1418. doi: 10.1016/j.euroneuro.2016.07.001. Epub 2016 Jul 21.

PMID:
27452144
40.

A comparison between wastewater-based drug data and an illicit drug use survey in a selected community.

van Wel JH, Kinyua J, van Nuijs AL, Salvatore S, Bramness JG, Covaci A, Van Hal G.

Int J Drug Policy. 2016 Aug;34:20-6. doi: 10.1016/j.drugpo.2016.04.003. Epub 2016 Apr 14.

PMID:
27450319
42.

Genetic and Environmental Contributions to the Association Between Cannabis Use and Psychotic-Like Experiences in Young Adult Twins.

Nesvåg R, Reichborn-Kjennerud T, Gillespie NA, Knudsen GP, Bramness JG, Kendler KS, Ystrom E.

Schizophr Bull. 2017 May 1;43(3):644-653. doi: 10.1093/schbul/sbw101.

43.

Exploring functional data analysis and wavelet principal component analysis on ecstasy (MDMA) wastewater data.

Salvatore S, Bramness JG, Røislien J.

BMC Med Res Methodol. 2016 Jul 12;16:81. doi: 10.1186/s12874-016-0179-2. Erratum in: BMC Med Res Methodol. 2017 Feb 23;17 (1):34.

44.

Psychosis induced by amphetamines.

Bramness JG, Rognli EB.

Curr Opin Psychiatry. 2016 Jul;29(4):236-41. doi: 10.1097/YCO.0000000000000254. Review.

PMID:
27175554
45.

Investigation of agreement between wastewater-based epidemiology and survey data on alcohol and nicotine use in a community.

van Wel JH, Gracia-Lor E, van Nuijs AL, Kinyua J, Salvatore S, Castiglioni S, Bramness JG, Covaci A, Van Hal G.

Drug Alcohol Depend. 2016 May 1;162:170-5. doi: 10.1016/j.drugalcdep.2016.03.002. Epub 2016 Mar 9.

PMID:
26980372
46.

The association between alcohol use and depressive symptoms across socioeconomic status among 40- and 45-year-old Norwegian adults.

Martinez P, Neupane SP, Perlestenbakken B, Toutoungi C, Bramness JG.

BMC Public Health. 2015 Nov 19;15:1146. doi: 10.1186/s12889-015-2479-6.

47.

The authors reply.

Bramness JG, Walby FA, Morken G, Røislien J.

Am J Epidemiol. 2015 Nov 1;182(9):820-1. doi: 10.1093/aje/kwv210. Epub 2015 Sep 30. No abstract available.

PMID:
26429999
48.

Correlates of major medication side effects interfering with daily performance: results from a cross-sectional cohort study of older psychiatric patients.

Tveito M, Correll CU, Bramness JG, Engedal K, Lorentzen B, Refsum H, Høiseth G.

Int Psychogeriatr. 2016 Feb;28(2):331-40. doi: 10.1017/S1041610215001544. Epub 2015 Sep 28.

PMID:
26412479
49.

The link between use of psychedelic drugs and mental health problems.

Nesvåg R, Bramness JG, Ystrom E, Suzanne Krebs T, Johansen PØ.

J Psychopharmacol. 2015 Sep;29(9):1035-6. doi: 10.1177/0269881115596156. No abstract available. Erratum in: J Psychopharmacol. 2016 Jun;30(6):581.

PMID:
26395581
50.

Wastewater-Based Epidemiology of Stimulant Drugs: Functional Data Analysis Compared to Traditional Statistical Methods.

Salvatore S, Bramness JG, Reid MJ, Thomas KV, Harman C, Røislien J.

PLoS One. 2015 Sep 22;10(9):e0138669. doi: 10.1371/journal.pone.0138669. eCollection 2015.

Supplemental Content

Loading ...
Support Center